Goldman Sachs Group Inc Gsk PLC Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$42.05 - $47.77 $342 Million - $389 Million	8,136,345 New	8,136,345 $354 Million
Q2 2022 Aug 15, 2022	BUY	$42.05 - $47.77 $43 Million - $48.9 Million	1,023,306 Added 14.39%	8,136,345 $354 Million
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $93.2 Million - $111 Million	2,316,204 Added 48.29%	7,113,039 $310 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $53.1 Million - $61.9 Million	1,365,400 Added 39.79%	4,796,835 $212 Million
Q3 2021 Nov 10, 2021	BUY	$38.79 - $43.16 $133 Million - $148 Million	3,431,435 New	3,431,435 $131 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.